CDKN2A and cervical carcinoma: Upon analyzing various sets of data and cross-referencing, CDH1, CDKN2A, RB1, and TP53 are putative biomarkers; these genes need to be studied for their role in diagnosing cervical cancer (Cardoso et al., 2017).